IM Cannabis Corp. announced on October 23, 2025, the signing of a non-binding indicative term sheet to acquire a 60% equity interest in a pioneering quantum computing bio data company. The aggregate consideration for this proposed acquisition is up to $54 million.
The consideration would be payable in a combination of cash, IMC shares, and potential earn-out payments tied to agreed performance milestones. This strategic move aligns with the company's previously announced decision to explore additional business activities to enhance long-term growth opportunities.
The target company specializes in utilizing quantum computing principles to store, manipulate, and analyze BIO data, offering advancements in biological data processing and analytics. The proposed transaction remains subject to due diligence, negotiation of definitive agreements, and all required corporate and regulatory approvals.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.